Hematology/Oncology

Top Story

Secondary surgery does not prolong survival in recurrent ovarian cancer

Secondary surgery does not prolong survival in recurrent ovarian cancer
November 13, 2019

Read the Perspective from Christina S. Chu, MD

In the Journals

Oral blood cancer drug may worsen cardiometabolic health

November 13, 2019
An oral chemotherapy treatment used to treat myeloproliferative neoplasms is associated with substantial weight gain and increased systolic blood pressure, according to…
Meeting News

Sitravatinib plus nivolumab safe, active in advanced urothelial carcinoma

November 13, 2019
NATIONAL HARBOR, Md. — The combination of sitravatinib and nivolumab induced encouraging clinical activity among patients with advanced urothelial carcinoma who…
In the JournalsPerspective

‘Running medicine’ improves health

November 13, 2019
“Running medicine” events that combined several types of exercise and community-building events improved participants’ physical and mental health and…
In the Journals

Melanoma rates decline among US adolescents, young adults

November 13, 2019
Incidence of invasive melanoma decreased among adolescents and young adults in the United States between 2006 and 2015, according to results of a population-based study…
More Headlines »
CME

Innovations in Sickle Cell Disease: How the Latest Advances May Impact Clinical Decision-making – Rapid Response From Amsterdam

This activity is supported by an educational grant from Global Blood Therapeutics.

Sickle cell disease (SCD) is an inherited molecular condition whose clinical severity has extreme phenotypic…
More »
Video
Meeting News

VIDEO: ASCO featured multiple exciting breast cancer studies

July 6, 2019
More »
Resource Centers
European Society for Medical Oncology Congress

European Society for Medical Oncology Congress

CME

Clinical Advances in Hepatocellular Carcinoma Management – Rapid Response from Chicago

This activity is supported by an educational grant from Merck & Co., Inc.

Hepatocellular carcinoma (HCC) is an aggressive tumor that is commonly diagnosed late in the course of the disease…
More »
Current Issues
View the Current Issue
HemOnc Today Cell Therapy Next